Sixty-nine unrelated Chinese DMD patients were studied with a series of genomic and cDNA probes. Analysis of 13 polymorphic sites showed that pERT87-1, 87-8, 87-15, and XJ probes gave favourable allele frequencies in the Chinese population, and nearly 90% of the DMD families in this study were informative for prenatal diagnosis and carrier detection using these four polymorphic markers. Nine out of 69 (13%) were also found to have gene deletions using a panel of genomic probes. However, when using cDNA probes, deletions were found in 56-5% of the patients. The deletions were concentrated in the areas of probes 7 and 8, giving a proportion of about 80% of all deleted patients in this study. All This paper reports our analysis of DNA from Chinese DMD patients using a panel of genomic and cDNA probes in the DMD gene, and the examination of RFLPs and DNA deletions at the DMD locus in Chinese.
used, the frequency of deletions has risen to more than 50%. This paper reports our analysis of DNA from Chinese DMD patients using a panel of genomic and cDNA probes in the DMD gene, and the examination of RFLPs and DNA deletions at the DMD locus in Chinese.
Materials and methods

SUBJECTS
One hundred normal Chinese subjects and 69 unrelated Chinese DMD patients were included in this study. All the patients had typical symptoms of DMD. Besides the clinical findings, the diagnosis was also based on a family history of DMD, significantly raised serum creatine kinase (CK) activity, pseudohypertrophy, hypertrophy of the calf muscles, and electromyography or muscle biopsy. DNA DMD cDNA probes 1-2a, 2b-3, 4-5a, 5b-7, 8, and 9-14 were obtained from the American Type Culture Collection. DNA deletions were detected by digesting the DNA samples with HindIII using the above cDNA fragments.
Results
The 13 RFLP sites examined in this study were all within Xp21 and the DMD locus. The alleles and frequencies of each polymorphic marker in the Chinese are presented in At present, DNA deletions in DMD can be examined using both genomic and cDNA probes. When genomic markers were used, the frequency of the deletions varied depending on the number of markers and on the methods used.12-16 Of the 69 DMD patients included in this study, deletions were found in nine (13%) unrelated patients. When 46 patients who were available for subsequent analysis were tested with cDNA probes, deletions were found in 26 patients (56-5%), which is in agreement with previously published reports using the same cDNA 
